D-MANOZINN® is a unique combination of d-mannose, beneficial bacteria in the protected Synbio® formulation (Lactobacillus rhamnosus, Lactobacillus paracasei) and saccharomycetes (Saccharomyces boulardii). This product has a beneficial effect on the urinary and gastrointestinal tract as well as on the immune system. It represents an efficient supplement to antibiotics in the treatment of urinary infections caused by the bacterium Escherichia coli.
Why D-MANOZINN® Protect?
- Through synergistic action of d-mannose, saccharomycetes and selected Lactobacillus strains, it increases the efficiency of antibiotic therapy in acute urinary infections caused by the bacterium E.coli
- Efficient in prevention of the development of recurrent infections (thanks to the probiotic cultures that protect ’good’ bacteria and maintain the composition and function of the physiological intestinal flora)
- Prevents the occurrence of adverse effects of antibiotic therapy
- Safe for administration in children older than 3 years, pregnant and breast-feeding women
- Comfortable administration – only one sachet a day
What does the product D-MANOZINN® Protect contains?
|Active ingredients||1 sachet|
|Saccharomyces boulardii SP9||1x109 CFU**|
|Lactobacillus rhamnosus IMC 501||5x108 CFU**|
|Lactobacillus paracasei IMC 502||5x108 CFU**|
**CFU – colony forming unit
How does D-MANOZINN® Protect work?
D-MANOZA – Bacterium Escherichia Coli binds to endogenous d-mannose in the urinary tract through its extensions (fimbriae). When taken orally, d-mannose binds to these bacterial extensions preventing thus binding of Escherichia Coli to endogenous mannose. The complex of orally taken d-mannose (from the product D-manozinn® Protect) and bacterium leaves the urinary tract fast and easy by next urination.
SYNBIO® – Represents a unique formulation of two Lactobacilus strains – L. rhamnosus and L. paracasei. These strains are natural inhabitants of digestive tract and vagina. The tests have shown that they bind to mucous membrane with the highest affinity where they form biofilm and have multiple positive effects. By producing lactic acid and hydrogen peroxide, they inhibit bacterial growth and reproduction, and L. rhamnosus has been shown to reduce the production of extensions (fimbriae) through which Escherichia coli is bound to the epithelium of the urinary tract. Probiotic strains stimulate the immune system activity and prevent the occurrence of diarrhoea in antibiotic therapy.
SACCHAROMYCES BOULARDII – A type of yeast that is non-pathogenic and antibiotic resistant. It effectively reduces the pathological strains of Escherichia coli, as it attaches to the bacterium by its adhesive outer sheath preventing thus the bacterium from binding to the urinary tract epithelium. In addition, it has a positive effect on the activation of the patient’s immune system and prevents diarrhoea during antibiotic therapy.
Method of use
Presentation: 10 sachets